Comerica Securities’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $10.2M | Sell |
18,923
-4,170
| -18% | -$2.15M | 0.84% | 22 |
|
|
2023
Q2 | $10.8M | Sell |
23,093
-1,571
| -6% | -$659K | 0.75% | 31 |
|
|
2023
Q1 | $8.47M | Buy |
24,664
+552
| +2% | +$186K | 0.61% | 42 |
|
|
2022
Q4 | $8.82M | Sell |
24,112
-582
| -2% | -$206K | 0.63% | 40 |
|
|
2022
Q3 | $7.99M | Sell |
24,694
-3,785
| -13% | -$1.2M | 0.66% | 38 |
|
|
2022
Q2 | $9.23M | Buy |
28,479
+21,091
| +285% | +$6.33M | 0.7% | 34 |
|
|
2022
Q1 | $2.12M | Sell |
7,388
-4,613
| -38% | -$1.19M | 0.14% | 145 |
|
|
2021
Q4 | $3.31M | Sell |
12,001
-271
| -2% | -$68.7K | 0.21% | 116 |
|
|
2021
Q3 | $2.83M | Sell |
12,272
-264
| -2% | -$65.2K | 0.2% | 124 |
|
|
2021
Q2 | $2.88M | Buy |
12,536
+6,944
| +124% | +$1.39M | 0.22% | 120 |
|
|
2021
Q1 | $1.04M | Sell |
5,592
-207
| -4% | -$40.5K | 0.08% | 214 |
|
|
2020
Q4 | $979K | Buy |
5,799
+507
| +10% | +$75.7K | 0.08% | 208 |
|
|
2020
Q3 | $783K | Buy |
5,292
+243
| +5% | +$37.6K | 0.07% | 213 |
|
|
2020
Q2 | $829K | Sell |
5,049
-45
| -0.9% | -$6.91K | 0.08% | 204 |
|
|
2020
Q1 | $707K | Sell |
5,094
-383
| -7% | -$52.6K | 0.08% | 202 |
|
|
2019
Q4 | $720K | Buy |
5,477
+95
| +2% | +$11K | 0.07% | 251 |
|
|
2019
Q3 | $602K | Buy |
5,382
+267
| +5% | +$29.7K | 0.06% | 252 |
|
|
2019
Q2 | $567K | Sell |
5,115
-819
| -14% | -$96.4K | 0.06% | 255 |
|
|
2019
Q1 | $770K | Buy |
5,934
+1,780
| +43% | +$216K | 0.09% | 218 |
|
|
2018
Q4 | $481K | Buy |
4,154
+1,854
| +81% | +$207K | 0.06% | 251 |
|
|
2018
Q3 | $247K | Buy |
+2,300
| New | +$230K | 0.03% | 379 |
|
|
2018
Q1 | – | Sell |
-4,792
| Closed | -$405K | – | 410 |
|
|
2017
Q4 | $405K | Sell |
4,792
-411
| -8% | -$35K | 0.05% | 288 |
|
|
2017
Q3 | $445K | Buy |
5,203
+402
| +8% | +$33K | 0.06% | 270 |
|
|
2017
Q2 | $395K | Buy |
4,801
+199
| +4% | +$16.2K | 0.06% | 276 |
|
|
2017
Q1 | $387K | Buy |
4,602
+211
| +5% | +$16.9K | 0.06% | 279 |
|
|
2016
Q4 | $323K | Buy |
4,391
+760
| +21% | +$56.6K | 0.13% | 166 |
|
|
2016
Q3 | $291K | Buy |
3,631
+230
| +7% | +$18.4K | 0.12% | 153 |
|
|
2016
Q2 | $268K | Buy |
3,401
+367
| +12% | +$27.6K | 0.13% | 156 |
|
|
2016
Q1 | $218K | Buy |
+3,034
| New | +$230K | 0.11% | 176 |
|
|
2015
Q3 | – | Sell |
-2,830
| Closed | -$236K | – | 284 |
|
|
2015
Q2 | $236K | Buy |
2,830
+83
| +3% | +$6.32K | 0.06% | 291 |
|
|
2015
Q1 | $200K | Buy |
+2,747
| New | +$196K | 0.05% | 295 |
|
Other funds holding LLY
Comerica Securities's LLY Position: Q3 2023 in Review
Comerica Securities reduced its Eli Lilly (LLY) stake by 18% in Q3 2023, selling an estimated $2.15M and leaving 18,923 shares worth $10.2M. The position accounts for 0.84% of the portfolio, ranked #22.
Comerica Securities first reported a position in LLY in Q1 2015 and has held it in 31 quarters since. The position peaked at $10.8M in Q2 2023. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.
- Comerica Securities held 18,923 shares of Eli Lilly worth $10.2M as of Q3 2023.
- Comerica Securities sold 4,170 Eli Lilly shares in Q3 2023, an estimated $2.15M.
- Eli Lilly made up 0.84% of Comerica Securities's portfolio in Q3 2023, its #22 holding.
- Comerica Securities first reported a position in Eli Lilly in Q1 2015 and has held it in 31 quarters since.
- Comerica Securities's Eli Lilly position peaked at $10.8M in Q2 2023.
- 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.
Based on Comerica Securities's 13F filing for Q3 2023, filed 26 Oct 2023.